Cargando…

Association Mining Identifies MAL2 as a Novel Tumor Suppressor in Colorectal Cancer

INTRODUCTION: Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide. However, the driver genes that promote CRC metastasis remain poorly understood. Association mining mines and extracts the repeated correlations and relevance in a dataset to predict the appearance of other d...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Kailai, Yang, Yanmei, Zheng, Shu, Hu, Wangxiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278979/
https://www.ncbi.nlm.nih.gov/pubmed/35847380
http://dx.doi.org/10.2147/OTT.S369670
_version_ 1784746292828700672
author Wang, Kailai
Yang, Yanmei
Zheng, Shu
Hu, Wangxiong
author_facet Wang, Kailai
Yang, Yanmei
Zheng, Shu
Hu, Wangxiong
author_sort Wang, Kailai
collection PubMed
description INTRODUCTION: Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide. However, the driver genes that promote CRC metastasis remain poorly understood. Association mining mines and extracts the repeated correlations and relevance in a dataset to predict the appearance of other data items according to the appearance of one item. METHODS: Here, the Apriori algorithm was used to find the frequent mutational gene sets (FMGSs) and hidden association rules (ARs) within these FMGSs from 383 CRCs with whole exome sequencing datasets. The weighted correlation network analysis (WGCNA) was used to identify the hub genes in CRC. CCK8, colony formation, cell migration and invasion assays were adopted to detect the roles of hub genes in CRC. RESULTS: Intriguingly, we found that MAL2 (myelin and lymphocyte protein 2) was associated with TP53 and APC in stage IV of CRC, and further subnetwork exploration based on WGCNA identified MAL2 as a potent hub gene. To validate the metastasis-related role of MAL2 in CRC, a lentivirus-based overexpression system was utilized to construct MAL2-overexpressing human CRC LOVO cells. Overexpression of MAL2 remarkably inhibited CRC cell proliferation and invasion. CONCLUSION: Our results highlighted that MAL2 acts as a tumor suppressor in CRC and could serve as a potential therapeutic target.
format Online
Article
Text
id pubmed-9278979
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-92789792022-07-14 Association Mining Identifies MAL2 as a Novel Tumor Suppressor in Colorectal Cancer Wang, Kailai Yang, Yanmei Zheng, Shu Hu, Wangxiong Onco Targets Ther Original Research INTRODUCTION: Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide. However, the driver genes that promote CRC metastasis remain poorly understood. Association mining mines and extracts the repeated correlations and relevance in a dataset to predict the appearance of other data items according to the appearance of one item. METHODS: Here, the Apriori algorithm was used to find the frequent mutational gene sets (FMGSs) and hidden association rules (ARs) within these FMGSs from 383 CRCs with whole exome sequencing datasets. The weighted correlation network analysis (WGCNA) was used to identify the hub genes in CRC. CCK8, colony formation, cell migration and invasion assays were adopted to detect the roles of hub genes in CRC. RESULTS: Intriguingly, we found that MAL2 (myelin and lymphocyte protein 2) was associated with TP53 and APC in stage IV of CRC, and further subnetwork exploration based on WGCNA identified MAL2 as a potent hub gene. To validate the metastasis-related role of MAL2 in CRC, a lentivirus-based overexpression system was utilized to construct MAL2-overexpressing human CRC LOVO cells. Overexpression of MAL2 remarkably inhibited CRC cell proliferation and invasion. CONCLUSION: Our results highlighted that MAL2 acts as a tumor suppressor in CRC and could serve as a potential therapeutic target. Dove 2022-07-09 /pmc/articles/PMC9278979/ /pubmed/35847380 http://dx.doi.org/10.2147/OTT.S369670 Text en © 2022 Wang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Wang, Kailai
Yang, Yanmei
Zheng, Shu
Hu, Wangxiong
Association Mining Identifies MAL2 as a Novel Tumor Suppressor in Colorectal Cancer
title Association Mining Identifies MAL2 as a Novel Tumor Suppressor in Colorectal Cancer
title_full Association Mining Identifies MAL2 as a Novel Tumor Suppressor in Colorectal Cancer
title_fullStr Association Mining Identifies MAL2 as a Novel Tumor Suppressor in Colorectal Cancer
title_full_unstemmed Association Mining Identifies MAL2 as a Novel Tumor Suppressor in Colorectal Cancer
title_short Association Mining Identifies MAL2 as a Novel Tumor Suppressor in Colorectal Cancer
title_sort association mining identifies mal2 as a novel tumor suppressor in colorectal cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278979/
https://www.ncbi.nlm.nih.gov/pubmed/35847380
http://dx.doi.org/10.2147/OTT.S369670
work_keys_str_mv AT wangkailai associationminingidentifiesmal2asanoveltumorsuppressorincolorectalcancer
AT yangyanmei associationminingidentifiesmal2asanoveltumorsuppressorincolorectalcancer
AT zhengshu associationminingidentifiesmal2asanoveltumorsuppressorincolorectalcancer
AT huwangxiong associationminingidentifiesmal2asanoveltumorsuppressorincolorectalcancer